Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 158
- No 13F data for Q4 2020
- Portfolio value
- $1.09B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | Stock | 429,200 | $80.2M | 7.4% | – | – | History |
| JNJJohnson & Johnson | Stock | 453,900 | $74.6M | 6.9% | – | – | History |
| ABBVAbbVie Inc. | Stock | 599,500 | $64.9M | 6.0% | – | – | History |
| MRKMerck & Co., Inc. | Stock | 808,808 | $62.4M | 5.7% | – | – | History |
| SNYSanofi | SPONSORED ADR | 997,900 | $49.4M | 4.5% | – | – | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 960,473 | $47.8M | 4.4% | – | – | History |
| GNRCGenerac Holdings Inc. | Stock | 105,663 | $34.6M | 3.2% | – | – | History |
| KURAKura Oncology, Inc. | COM | 717,751 | $20.3M | 1.9% | – | – | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 497,136 | $18.4M | 1.7% | – | – | History |
| MSFTMicrosoft Corp | Stock | 67,536 | $15.9M | 1.5% | – | – | History |
| KRNTKornit Digital Ltd. | SHS | 148,381 | $14.7M | 1.4% | – | – | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 638,093 | $14.3M | 1.3% | – | – | History |
| LPSNLiveperson Inc | COM | 260,000 | $13.7M | 1.3% | – | – | History |
| EPIXESSA Pharma Inc. | COM NEW | 469,241 | $13.6M | 1.3% | – | – | History |
| AUDCAudiocodes Ltd | ORD | 475,624 | $12.8M | 1.2% | – | – | History |
| BMYBristol Myers Squibb Co | Stock | 200,000 | $12.6M | 1.2% | – | – | History |
| ONCROncorus, Inc. | COM | 903,111 | $12.6M | 1.2% | – | – | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 912,240 | $12.5M | 1.2% | – | – | History |
| PANWPalo Alto Networks Inc | Stock | 32,300 | $10.4M | 1.0% | – | – | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 137,672 | $10.1M | 0.9% | – | – | History |
| CRISCuris Inc | COM NEW | 885,838 | $10.0M | 0.9% | – | – | History |
| ORTXOrchard Therapeutics plc | ADS | 1,366,564 | $9.92M | 0.9% | – | – | History |
| KYMRKymera Therapeutics, Inc. | COM | 247,527 | $9.62M | 0.9% | – | – | History |
| ALXOAlx Oncology Holdings Inc | COM | 130,351 | $9.61M | 0.9% | – | – | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 832,878 | $9.61M | 0.9% | – | – | History |
| FATEFate Therapeutics Inc | COM | 109,807 | $9.05M | 0.8% | – | – | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 4,177,158 | $8.90M | 0.8% | – | – | History |
| ZLABZai Lab Ltd | ADR | 65,788 | $8.78M | 0.8% | – | – | History |
| NICENICE Ltd. | SPONSORED ADR | 39,481 | $8.61M | 0.8% | – | – | History |
| AMZNAmazon Com Inc | Stock | 2,761 | $8.54M | 0.8% | – | – | History |
| ONTOOnto Innovation Inc. | COM | 125,000 | $8.21M | 0.8% | – | – | History |
| SGTXSigilon Therapeutics, Inc. | COM | 362,239 | $8.07M | 0.7% | – | – | History |
| Affimed N VN01045108 | COM | 1,018,965 | $8.06M | 0.7% | – | – | – |
| BOLTBolt Biotherapeutics, Inc. | COM | 241,000 | $7.93M | 0.7% | – | – | History |
| RPTXRepare Therapeutics Inc. | COM | 248,100 | $7.61M | 0.7% | – | – | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 175,140 | $7.60M | 0.7% | – | – | History |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 720,000 | $7.57M | 0.7% | – | – | – |
| Mohawk Group Hldgs Inc608189106 | COM | 251,015 | $7.41M | 0.7% | – | – | – |
| CSTECaesarstone Ltd. | ORD SHS | 535,148 | $7.35M | 0.7% | – | – | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 167,799 | $7.32M | 0.7% | – | – | History |
| ONCBeOne Medicines Ltd. | ADR | 20,900 | $7.28M | 0.7% | – | – | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 687,900 | $7.27M | 0.7% | – | – | – |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 670,459 | $7.20M | 0.7% | – | – | – |
| VRNSVaronis Systems Inc | COM | 138,675 | $7.12M | 0.7% | – | – | History |
| Cyberark Software LtdM2682V108 | SHS | 55,000 | $7.11M | 0.7% | – | – | – |
| DYNDyne Therapeutics, Inc. | COM | 450,064 | $6.99M | 0.6% | – | – | History |
| ALLTAllot Ltd. | SHS | 420,205 | $6.71M | 0.6% | – | – | History |
| STROSutro Biopharma, Inc. | COM | 294,825 | $6.71M | 0.6% | – | – | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 801,256 | $6.70M | 0.6% | – | – | History |
| COGTCogent Biosciences, Inc. | COM | 762,569 | $6.70M | 0.6% | – | – | History |
| NRIXNurix Therapeutics, Inc. | COM | 215,076 | $6.69M | 0.6% | – | – | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 258,880 | $6.65M | 0.6% | – | – | History |
| IONSIonis Pharmaceuticals Inc | COM | 145,476 | $6.54M | 0.6% | – | – | History |
| RACBResearch Alliance Corp. II | COM CL A | 600,000 | $6.15M | 0.6% | – | – | History |
| STOKStoke Therapeutics, Inc. | COM | 150,729 | $5.85M | 0.5% | – | – | History |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 400,000 | $5.51M | 0.5% | – | – | – |
| BIDUBaidu, Inc. | ADR | 25,000 | $5.44M | 0.5% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 202,134 | $5.24M | 0.5% | – | – | History |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $5.20M | 0.5% | – | – | History |
| MRTXMirati Therapeutics, Inc. | COM | 29,779 | $5.10M | 0.5% | – | – | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 300,000 | $4.96M | 0.5% | – | – | – |
| Rada Electr Inds LtdM81863124 | COM PAR NEW | 407,925 | $4.90M | 0.5% | – | – | – |
| IDYAIDEAYA Biosciences, Inc. | COM | 201,984 | $4.75M | 0.4% | – | – | History |
| Reinvent Technology PartnersG74847107 | SHS CL A | 468,012 | $4.68M | 0.4% | – | – | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 220,320 | $4.54M | 0.4% | – | – | History |
| MREOMereo BioPharma Group plc | SPON ADS | 1,312,415 | $4.42M | 0.4% | – | – | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 284,224 | $4.34M | 0.4% | – | – | History |
| Farfetch Ltd30744W107 | ORD SH CL A | 80,000 | $4.24M | 0.4% | – | – | – |
| ORICOric Pharmaceuticals, Inc. | COM | 169,900 | $4.16M | 0.4% | – | – | History |
| Foresight Acquisition Corp34552Y205 | UNIT 01/29/2026 | 420,000 | $4.16M | 0.4% | – | – | – |
| STTKShattuck Labs, Inc. | COM | 140,665 | $4.11M | 0.4% | – | – | History |
| ARKOARKO Corp. | COM | 408,000 | $4.06M | 0.4% | – | – | History |
| Healthcare Capital Corp42228C200 | UNIT 12/31/2025 | 400,000 | $3.95M | 0.4% | – | – | – |
| IFRXInflaRx N.V. | COM | 1,000,000 | $3.90M | 0.4% | – | – | History |
| KAKineta, Inc. | COM | 208,609 | $3.78M | 0.3% | – | – | History |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 1,294,000 | $3.74M | 0.3% | – | – | – |
| Bio Green Med Solution, Inc.23254L603 | COM | 508,322 | $3.61M | 0.3% | – | – | – |
| NKTXNkarta, Inc. | COM | 101,006 | $3.32M | 0.3% | – | – | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 212,600 | $3.27M | 0.3% | – | – | – |
| EWTXEdgewise Therapeutics, Inc. | COM | 100,000 | $3.25M | 0.3% | – | – | History |
| LVTXLAVA Therapeutics NV | SHS | 213,894 | $3.25M | 0.3% | – | – | History |
| Longview Acquisition Corp. II54319Q204 | UNIT 99/99/9999 | 300,000 | $3.01M | 0.3% | – | – | – |
| Eucrates Biomedical Acqu CorG3141W106 | SHS | 304,025 | $3.01M | 0.3% | – | – | – |
| Clarim Acquisition Corp18049C207 | UNIT 99/99/9999 | 300,000 | $2.98M | 0.3% | – | – | – |
| GRTXGalera Therapeutics, Inc. | COM | 323,348 | $2.85M | 0.3% | – | – | History |
| DMRADamora Therapeutics, Inc. | COM | 448,016 | $2.72M | 0.3% | – | – | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 54,962 | $2.66M | 0.2% | – | – | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 750,000 | $2.60M | 0.2% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 9,249 | $2.55M | 0.2% | – | – | History |
| IMVTImmunovant, Inc. | COM | 158,500 | $2.54M | 0.2% | – | – | History |
| SNCEScience 37 Holdings, Inc. | COM | 244,000 | $2.47M | 0.2% | – | – | History |
| FNCHFinch Therapeutics Group, Inc. | COM | 150,000 | $2.39M | 0.2% | – | – | History |
| CAMTCamtek Ltd | ORD | 79,746 | $2.38M | 0.2% | – | – | History |
| TILInstil Bio, Inc. | COM | 95,000 | $2.38M | 0.2% | – | – | History |
| INBXInhibrx Biosciences, Inc. | COM | 114,643 | $2.30M | 0.2% | – | – | History |
| Turmeric Acquisition CorpG9127T108 | CL A | 219,440 | $2.14M | 0.2% | – | – | – |
| ALPNAlpine Immune Sciences, Inc. | COM | 198,260 | $2.10M | 0.2% | – | – | History |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 172,396 | $2.06M | 0.2% | – | – | – |
| ALITAlight, Inc. / Delaware | COM CL A | 200,000 | $2.01M | 0.2% | – | – | History |
| HYPRHyperfine, Inc. | CL A SHS | 200,000 | $2.00M | 0.2% | – | – | History |
Options (12)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| iShares Russell 2000 ETF464287655 | ETF | $46.4M | – |
| ENPHEnphase Energy, Inc. | Stock | – | $37.3M |
| JNJJohnson & Johnson | Stock | – | $32.9M |
| iShares Tr464287515 | EXPANDED TECH | $24.2M | – |
| FVRRFiverr International Ltd. | ORD SHS | – | $21.7M |
| Mohawk Group Hldgs Inc608189106 | COM | – | $10.5M |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $10.3M |
| iShares Global Clean Energy ETF464288224 | ETF | $10.2M | – |
| PRGOPERRIGO Co plc | SHS | – | $8.50M |
| iShares Tr464287432 | 20 YR TR BD ETF | $8.13M | – |
| Global X FDS37954Y442 | CLOUD COMPUTNG | $4.39M | – |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | – | $1.01M |